Page 90 - ebook
P. 90

[A. Biochemistry/Molecular Biology] A-45



                 Transcriptome-wide off-target analysis of RNA-targeting


                                          type-VI CRISPR system




                                           #
                           Seong-Ho Park¹ , Seokju Park⁴ , Jin Wu Nam⁴,⁵,⁶*, Junho K Hur¹,³*
                                                          #
          ¹Department of Medicine, Major in Medical Genetics, Graduate School, Hanyang University, Seoul 04736, Korea,

         ²Graduate School of Biomedical Science & Engineering, Hanyang University, Seoul 04736, Korea, ³Department of

         Genetics, College of Medicine, Hanyang University, Seoul 04736, Korea, ⁴Department of Life Sciences, College of
            Natural Science, Hanyang University, Seoul 04736, Korea, ⁵Research Institute for Natural Sciences, Hanyang
                                               University, Seoul 04736, Korea





        The CRISPR/Cas systems are known as the 3rd generation gene-editing tool, and have been mostly applied for
        DNA editing. CRISPR/Cas systems are widely studied in biological and medical research fields as the CRISPR systems

        can conduct direct editing of DNA to permanently change the genome. However, one o the safety concerns of the
        CISPR/Cas systems have been off-target effects, that induces unanticipated DNA sequence changes in the genome.

        Many studies have been trying to overcome the off-target issue by developing highly precise CRISPR/Cas systems
        for gene therapy. To this end, CRISPR-Cas13, an RNA editing CRISPR system, had been studied as a tool for targeted

        gene regulation without DNA changes. However, the Cas13 had not widely used research because of low RNA
        editing efficiency. According to a recent study, the CasRX, a type of Cas13d, was high efficiency and small size, it

        was an advantage in virus loading. In this study, we performed that degradome-seq for detected of the cleavage
        site  in  RNA  for  observed  the  off-target  effect,  the  disadvantage  of  the  CRISPR/Cas  system,  in  CasRX.  And  we
        researched guide RNA screening for optimized gRNA design.
   85   86   87   88   89   90   91   92   93   94   95